Clinical trial
Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization
NCT02260687 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 5, 2014
- Completion date
- August 22, 2018
- Enrollment
- 353 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.